
PMC:7299399 / 8532-8718
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T45","span":{"begin":21,"end":37},"obj":"Disease"},{"id":"T46","span":{"begin":94,"end":102},"obj":"Disease"}],"attributes":[{"id":"A45","pred":"mondo_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A46","pred":"mondo_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"pting to treat other viral infections. Overviews of the identification of candidate drugs for SARS-CoV-2 are detailed in refs (29−31).\nIn the past decade, there has been growing interest"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T83","span":{"begin":161,"end":164},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"pting to treat other viral infections. Overviews of the identification of candidate drugs for SARS-CoV-2 are detailed in refs (29−31).\nIn the past decade, there has been growing interest"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T37","span":{"begin":84,"end":89},"obj":"Chemical"}],"attributes":[{"id":"A37","pred":"chebi_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"pting to treat other viral infections. Overviews of the identification of candidate drugs for SARS-CoV-2 are detailed in refs (29−31).\nIn the past decade, there has been growing interest"}
LitCovid-PD-GO-BP
{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T18","span":{"begin":21,"end":37},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":"pting to treat other viral infections. Overviews of the identification of candidate drugs for SARS-CoV-2 are detailed in refs (29−31).\nIn the past decade, there has been growing interest"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T41","span":{"begin":39,"end":134},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"pting to treat other viral infections. Overviews of the identification of candidate drugs for SARS-CoV-2 are detailed in refs (29−31).\nIn the past decade, there has been growing interest"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"166","span":{"begin":94,"end":104},"obj":"Species"},{"id":"167","span":{"begin":21,"end":37},"obj":"Disease"}],"attributes":[{"id":"A166","pred":"tao:has_database_id","subj":"166","obj":"Tax:2697049"},{"id":"A167","pred":"tao:has_database_id","subj":"167","obj":"MESH:D001102"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"pting to treat other viral infections. Overviews of the identification of candidate drugs for SARS-CoV-2 are detailed in refs (29−31).\nIn the past decade, there has been growing interest"}
2_test
{"project":"2_test","denotations":[{"id":"32519842-32194980-158464","span":{"begin":127,"end":129},"obj":"32194980"}],"text":"pting to treat other viral infections. Overviews of the identification of candidate drugs for SARS-CoV-2 are detailed in refs (29−31).\nIn the past decade, there has been growing interest"}